STUDI ANALISIS EFEK SAMPING KEMOTERAPI PADA PASIEN KANKER PAYUDARA DI RSUD DR. H. ABDUL MOELOEK PROVINSI LAMPUNG TAHUN 2023
STUDY ANALYSIS OF SIDE EFFECTS OF CHEMOTHERAPY IN BREAST CANCER PATIENTS AT DR. H. ABDUL MOELOEK LAMPUNG PROVINCE YEAR 2023
DOI:
https://doi.org/10.37090/jfl.v14i1.2446Abstract
The high mortality rate in breast cancer and with the most malignancy attacking women, therapy is needed in the treatment of breast cancer by chemotherapy. Chemotherapy works by killing rapidly dividing cancer cells. However, due to its non-selective nature, chemotherapy also affects healthy cells and causes side effects that affect the patient's quality of life. This study aims to determine the side effects of chemotherapy in breast cancer patients at Dr. H. Abdul Moeloek Hospital, Lampung Province in 2023. This type of research is a qualitative descriptive observational study with a cross-sectional design and accidental sampling data collection techniques. Data analysis was done descriptively in the form of a percentage. The sample in this study was 41 patients. The results of the study based on the characteristics of female gender were 41 patients (100%) and male patients were 0 patients (0%), the age of the diagnosed patients was in the age range of 36-45 years as many as 13 patients (31.7%), 46-55 years as many as 13 patients (31.7%), and 56-65 years as many as 13 patients (13.7%), based on the patient's occupation with the occupation of a housewife (IRT) as many as 24 patients (58.5%), treatment with the TdCar regimen (Taxane (docetaxel), Carboplatin) as many as 13 patients (26.9%) and the AC regimen (Doxorubicin, Cyclophosphamide) as many as 11 patients (21.2%). The conclusion of this study is the side effects using the Naranjo algorithm, the score obtained is between 1-4 (possible) which means that there may be an ADR. The most common side effects suffered by breast cancer chemotherapy patients at Dr. Soetomo Hospital. H. Abdul Moeloek Lampung Province in 2023 was hair loss (87.8%).
Keywords: Side Effects, Breast Cancer, Chemotherapy, Cross-sectional
Downloads
References
[1] Amalia. 2009. Mengobati Kanker Serviks dan 33 Jenis Kanker Lainnya. Yogyakarta Landscape.
[2] Katzung BG. 2012. Farmakologi Dasar dan Klinik. XII. Jakarta: EGC.
Vol. II.
[3] Masriadi. 2016. Epidemiologi Penyakit Tidak Menular. Jakarta: Trans Info Media.
[4] Efendi JAlJ, Anggun N. 2019. Studi Efek Samping Penggunaan Obat Kemotrapi Pasien Kanker Payudara (Carcinoma Mammae) di RSUD Kraton Pekalongan. Jurnal Kesehatan Pena Medika. Vol. 9(2):48–54.
[5] WHO, 2020. International Agency for Research on Cancer: Indonesia. World Health Organization.
[6] Menteri Kesehatan Republik Indonesia. 2018. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Kanker Payudara. HK. 01.07/MENKES/414/2018.
[7] RSUD Dr. H. Abdul Moeloek Provinsi Lampung. 2023. Profil dan Sejarah Berdirinya RSUD Dr. H. Abdul Moeloek Provinsi Lampung.
[8] Sofa T, Wardiyah A, Rilyani. 2023. Faktor Risiko Kanker Payudara Pada Wanita. Jurnal Penelitian Perawat Profesional Vol. 6.
[9] Ramli M. 2001. Deteksi Dini Kanker. Balai Penerbit Fakultas Kedokteran Universitas Indonesia.
[10] Lullmann H, Mohr K, Ziegler A, Bieger D. 2000. Color Atlas of Pharmacology. . New York 2nd ed.
[11] Halim A. 2015. Karakteristik Anemia Pada Penderita Kanker Payudara Di RSUD Dr. Zainoel Abidin Banda Aceh Tahun 2015. Universitas Syiah Kuala Darussalam Banda Aceh Jurnal Kedokteran.
[12] Wijayanti Nunuk, Rahmawati Fita, Pramugyono. 2023. Kajian Efek Samping Obat Kemoterapi Dosetaksel Pada Kanker Payudara di RS Bhayangkara Kediri, Jurnal Managemen Dan Pelayanan Farmasi, Vol. 13No. 3 : 153-165.
[13] Faisel CTW. 2013. Gambaran Efek Samping Kemoterapi Berbasis Antrasiklin Pada Pasien Kanker Payudara di RSUD Dokter Soedarso Pontianak. FK Universitas Tanjungpura. Jurnal Mahasiswa PSPD. Vol.1(1).
[14] Partridge AH, Burstein HJ, Winer EP. 2001. Side Effects of Chemotherapy and Combined Chemohormonal Therapy in Women With Breast Cancer. J Natl Cancer Inst Monogr. Vol. 30:135–42.
[15] Bustan M N. 2007. Epidemiologi Penyakit Tidak Menular. Rineka Cipta Jakarta. Cetakan II.
[16] Barone I, Giordano C, Bonofiglio D, Ando S, Catalano S. 2020. The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives. Seminar in Cancer Biologi. 60:274–84.
